tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
SUPN
Supernus Pharmaceuticals
RESEARCH TOOLSreports
Want to see SUPN full AI Analyst Report?

Supernus Pharmaceuticals (SUPN) Revenue

530 Followers
StatisticsMarket CapRevenue

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had a revenue of 207.71M in the quarter ending Mar 31, 2026, with -1.83%. This bring the company's revenue in the last twelve months to 776.83M, Decreased 8.05%. In the fiscal year ending Dec 31, 2025, Supernus Pharmaceuticals had annual revenue of 718.95M with 8.63% growth.
Revenue (ttm)
776.83M
Revenue Growth
16.29%
P/S Ratio
3.91
Revenue/Employee
$1,066,694
Employees
674
Market Cap
$2.81B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
718.95M57.13M+8.63%
Dec 31, 2024
661.82M54.30M+8.94%
Dec 31, 2023
607.52M-59.72M-8.95%
Dec 31, 2022
667.24M87.46M+15.09%
Dec 31, 2021
579.77M59.38M+11.41%
Dec 31, 2020
520.40M127.64M+32.50%
Dec 31, 2019
392.75M-16.14M-3.95%
Dec 31, 2018
408.90M106.66M+35.29%
Dec 31, 2017
302.24M――